Chemotherapeutic and surgical strategies for germ cell tumors

Chest Surgery Clinics of North America

Volumn 12, Issue 4, 2002, Pages 695-706

  Einhorn, Lawrence H ^a,b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WALTHER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; ETOPOSIDE; GEMCITABINE; IFOSFAMIDE; PACLITAXEL; VINBLASTINE;

ABDOMINAL CRAMP; CANCER COMBINATION CHEMOTHERAPY; CANCER RISK; CANCER SURGERY; DOSE RESPONSE; DRUG EFFICACY; GERM CELL TUMOR; GRANULOCYTOPENIA; HUMAN; ILEUS; MALE; MEDIASTINUM TUMOR; MYALGIA; NEUROMUSCULAR DISEASE; OVARY CANCER; PARESTHESIA; PRIORITY JOURNAL; REVIEW; TESTIS CANCER;

EID: 0036853913     PISSN: 10523359     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1052-3359(02)00029-7     Document Type: Review

References (41)

1. Einhorn LH. Treatment of testicular cancer: A new and improved model. J Clin Oncol 1990;8(11):1777-81.
2. Whitmore WF. Surgical treatment of adult germinal testis tumors. Semin Oncol 1979;6:55-68.
3. Donohue JP, Zachart JM, Maynard BR. Distribution of nodal metastases in non-seminomatous testis cancer. J Urol 1982;128:315-20.
4. Li MC, Whitmore WF, Golbey R, et al. Effects of combined drug therapy on metastatic cancer of the testis. JAMA 1960;174:145-53.
5. Samuels ML, Lanzotti VJ, Holoye PY, et al. Combination chemotherapy in germinal cell tumors. Cancer Treat Rev 1976;3:185-204.
6. Rosenberg B, VanCamp L, Krigas T. Inhibition of cell division in E coli by electrolysis products from a platinum electrode. Nature 1965;205:678-99.
7. Higby DJ, Wallace HJ, Albert DJ, et al. Diamine dichloroplatinum: A phase I study showing responses in testicular and other tumors. Cancer 1974;33:1219-25.
8. Einhorn LH, Donohue JP. Combination chemotherapy with cisdiamine dichloroplatinum, vinblastine, and bleomycin in disseminated testicular cancer. Ann Intern Med 1977;87(3):293-8.
9. Einhorn LH, Williams SD. Chemotherapy of disseminated testicular cancer: A randomized prospective study. Cancer 1980;46:1339-44.
10. Einhorn LH, Williams SD, Mandelbaum I, Donohue JP. Surgical resection in disseminated testicular cancer following chemotherapeutic cytoreduction. Cancer 1981;48:904-8.
11. Stoter G, Sleyfer DT, Bokkel Huinink WW, et al. High dose versus low dose vinblastine in PVB: A randomized study of the EORTC. J Clin Oncol 1986;4:1199-206.
12. Einhorn LH, Williams SD, Troner M, Greco FA, Birch R. The rise of maintenance therapy in disseminated testicular cancer: A Southeastern Cancer Study Group Protocol. N Engl J Med 1981;305:717-31.
13. Bosl GJ, Gluckman R, Geller NL, et al. VAB-6: An effective chemotherapy regimen for patients with germ cell tumors. J Clin Oncol 1986;4:1493-9.
14. Fitzharris BM, Kaye SB, Saverymuttu S, et al. VP-16 as single agent in advanced testicular tumors. Eur J Cancer 1980;16:1193-7.
15. Schabel Jr FM, Trader MW, Laster Jr WR, et al. Cisplatin: Combination chemotherapy and cross-resistance studies with tumors of mice. Cancer Treat Rep 1979;63:1459-73.
16. Williams SD, Birch R, Irwin L, Greco A, Loehrer PJ, Einhorn LH. Disseminated germ cell tumors: Chemotherapy with cisplatin plus bleomycin plus either vinblastine or etoposide. N Engl J Med 1987;316:1435-40.
17. Birch R, Williams SD, Cone A, Einhorn LH, et al. Prognostic factors for favorable outcome in disseminated gem cell tumors. J Clin Oncol 1986;4:400-7.
18. Einhorn LH, Williams SD, Loehrer PJ, et al. Evaluation of optimal duration of chemotherapy in favorable prognosis disseminated germ cell tumors: An SECSG protocol. J Clin Oncol 1989;7:387-91.
19. Saxman S, Finch D, Gonin R, Einhorn LH. Long-term follow-up of a phase III study of 3 versus 4 cycles of bleomycin, etoposide, and cisplatin in favorable prognosis germ cell tumors. J Clin Oncol 1998;16:702-6.
20. Loehrer PJ, Einhorn LH, Elson P, et al. The importance of bleomycin in favorable prognosis disseminated germ cell tumors: an Eastern Cooperative Oncology Group Trial. J Clin Oncol 1995;13:470-6.
21. Bajorin D, Sarosdy MF, Pfister DG, et al. Randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good-risk germ cell tumors. J Clin Oncol 1993;11:598-608.
22. Horwich A, Sleijfer DT, Fossa SD, et al. Randomized trial of bleomycin, etoposide and cisplatin compared with bleomycin, etoposide and carboplatin in good prognosis metastatic non-seminomatous germ cell cancer. J Clin Oncol 1997;15:1844-52.
23. Hartman JT, Einhorn L, Nichols CR, et al. Second-line chemotherapy in patients with relapsed extragonadal non-seminomatous germ cell tumors: Results of an international multicenter analysis. J Clin Oncol 2001;19:1641-8.
24. Bosl GJ, Geller NL, Cirrincione C, et al. Multivariate analysis of prognostic variables in patients with metastatic testicular cancer. Cancer Res 1983;43:3402-7.
25. International Germ Cell Collaborative Group. International germ cell consensus classification: A prognostic factor-based staging system for metastatic germ cell cancers. J Clin Oncol 1997;15:594-603.
26. Nichols CR, Williams SD, Einhorn H, et al. Randomized study of cisplatin dose intensity in advanced germ cell tumors: An SECSG and SWOG protocol. J Clin Oncol 1991;9:1163-72.
27. Nichols CR, Catalona PJ, Crawford ED, et al. Randomized comparison of cisplatin plus etoposide plus either bleomycin or ifosfamide treatment of advanced disseminated germ cell tumors. J Clin Oncol 1998;16:1287-91.
28. Loehrer PJ, Gonin R, Nichols CR, Weathers T, Einhorn LH. Vinblastine plus ifosfamide plus cisplatin as initial salvage therapy in recurrent germ cell tumors. J Clin Oncol 1998;16:2500-6.
29. Broun ER, Nichols CR, Einhorn LH, et al. Long-term follow-up of salvage chemotherapy in relapsed and refractory germ cell tumors using high dose carboplatin and etoposide with autologous bone marrow support. Ann Intern Med 1992;117:124-8.
30. Bhatia S, Abonour R, Porcu P, et al. High dose chemotherapy as initial salvage chemotherapy in patients with relapsed testicular cancer. J Clin Oncol 2000;18:3346-51.
31. Miller KD, Loehrer PJ, Gonin R, Einhorn LH. Salvage chemotherapy with vinblastine, ifosfamide, and cisplatin in recurrent seminoma. J Clin Oncol 1997;15:1427-31.
32. Miller J, Einhorn LH. Daily oral VP-16 in refractory germ cell tumors. Semin Oncol 1990;17:36-9.
33. Einhorn LH, Stender MJ, Williams SD. Phase II trial of paclitaxel shows antitumor activity in patients with previously treated germ cell tumors. J Clin Oncol 1999;17:509-11.
34. Motzer RJ, Bajorin DF, Schwartz LH, et al. Phase II trial of paclitaxel shows antitumor activity in patients with previously treated germ cell tumors. J Clin Oncol 1994;12:2277-83.
35. Hinton S, Catalano P, Einhorn LH, et al. Phase II study of paclitaxel plus gemcitabine in refractory germ cell tumors: A trial of the Eastern Cooperative Oncology Group. J Clin Oncol 2002;20:1859-63.
36. Ganjoo KN, Rieger KM, Kesler KA, et al. Results of modern therapy for patients with mediastinal non-seminomatous germ cell tumors. Cancer 2000;88:1051-6.
37. Saxman SB, Nichols CR, Einhorn LH. Salvage chemotherapy in patients with extragonadal non-seminomatous germ cell tumors: The Indiana University Experience. J Clin Oncol 1994;12:1390-3.
38. Schultz SM, Einhorn LH, Conces D, et al. Management of post-chemotherapy residual mass in patients with advanced seminoma: Indiana University Experience. J Clin Oncol 1989;7:1497-503.
39. Horwich A, Paluchowska B, Norman A, et al. Residual mass following chemotherapy of seminoma. Ann Oncol 1997;8:37-40.
40. Debono DJ, Heilman DK, Einhorn LH, Donohue JP. Decision analysis for avoiding post-chemotherapy surgery in patients with disseminated non-seminomatous germ cell tumors. J Clin Oncol 1997;15:1455-64.
41. Baniel J, Foster RS, Gonin R, et al. Late relapse of testicular cancer. J Clin Oncol 1995;13:1170-6.